Literature DB >> 27456240

Psychological side effects of immune therapies: symptoms and pathomechanism.

David Kovacs1, Peter Kovacs2, Nora Eszlari3, Xenia Gonda4, Gabriella Juhasz5.   

Abstract

Immunotherapies revolutionised the treatment of several disorders but show specific side-effect profiles which frequently involve psychological symptoms. Long term interferon-alpha (IFN-alpha) therapy can cause wide-ranging psychiatric side-effects from fatigue, insomnia, anxiety to full-blown depression. This treatment-emergent depression shares several symptoms with major depressive disorder (MDD) with a predominance of somatic/neurovegetative symptoms, and can be treated with antidepressants. However, this experience directed research to inflammatory mechanisms in MDD. MDD has been confirmed as a heterogeneous disorder with a subgroup of patients suffering from low-grade chronic inflammation and frequently resistant to traditional antidepressant treatment. Thus future research should develop strategies to identify those MDD patients who could benefit from drugs acting through inflammatory pathways.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27456240     DOI: 10.1016/j.coph.2016.06.008

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  8 in total

Review 1.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

2.  Effects of Peripheral Immune Challenge on In Vivo Firing of Basolateral Amygdala Neurons in Adult Male Rats.

Authors:  Soumyabrata Munshi; J Amiel Rosenkranz
Journal:  Neuroscience       Date:  2018-08-29       Impact factor: 3.590

3.  FKBP51 mediates resilience to inflammation-induced anxiety through regulation of glutamic acid decarboxylase 65 expression in mouse hippocampus.

Authors:  Yu-Ling Gan; Chen-Yu Wang; Rong-Heng He; Pei-Chien Hsu; Hsin-Hsien Yeh; Tsung-Han Hsieh; Hui-Ching Lin; Ming-Yen Cheng; Chung-Jiuan Jeng; Ming-Chyi Huang; Yi-Hsuan Lee
Journal:  J Neuroinflammation       Date:  2022-06-15       Impact factor: 9.587

Review 4.  Exosomal biomarkers in Down syndrome and Alzheimer's disease.

Authors:  Eric D Hamlett; Aurélie Ledreux; Huntington Potter; Heidi J Chial; David Patterson; Joaquin M Espinosa; Brianne M Bettcher; Ann-Charlotte Granholm
Journal:  Free Radic Biol Med       Date:  2017-09-05       Impact factor: 7.376

5.  A murine model of Lyme disease demonstrates that Borrelia burgdorferi colonizes the dura mater and induces inflammation in the central nervous system.

Authors:  Timothy Casselli; Ali Divan; Emilie E Vomhof-DeKrey; Yvonne Tourand; Heidi L Pecoraro; Catherine A Brissette
Journal:  PLoS Pathog       Date:  2021-02-01       Impact factor: 6.823

6.  A Cross-Sectional Study on the Relationship Among Cytokines, 5-HT2A Receptor Polymorphisms, and Sleep Quality of Non-manual Workers in Xinjiang, China.

Authors:  Juan Wang; Xiaoyan Gao; Pengcheng Gao; Jiwen Liu
Journal:  Front Psychiatry       Date:  2022-04-06       Impact factor: 4.157

7.  No bidirectional relationship between depression and periodontitis: A genetic correlation and Mendelian randomization study.

Authors:  Michael Nolde; Birte Holtfreter; Thomas Kocher; Zoheir Alayash; Stefan Lars Reckelkamm; Benjamin Ehmke; Hansjörg Baurecht; Sebastian-Edgar Baumeister
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

8.  Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.

Authors:  Anne Rogiers; Christophe Leys; Justine Lauwyck; Adrian Schembri; Gil Awada; Julia Katharina Schwarze; Jennifer De Cremer; Peter Theuns; Paul Maruff; Mark De Ridder; Jan L Bernheim; Bart Neyns
Journal:  J Immunol Res       Date:  2020-07-21       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.